CVRx, Inc. (CVRX) vs Hyperfine, Inc. (HYPR)
CVRx, Inc. and Hyperfine, Inc. are both Medical Devices companies. Hyperfine, Inc. is the larger, with a market value of $84.4M against $67.4M — 1.3× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 12.0%. CVRx, Inc. has the higher net margin (−84.9% vs −210.8%) and the higher return on invested capital (−218.1% vs −401.8%). Across the 18 metrics below, CVRx, Inc. leads on 10 and Hyperfine, Inc. on 8.
Valuation
Profitability
| Metric | CVRX | HYPR | Medical Devices median |
|---|---|---|---|
| Gross margin | 86.92% | 51.41% | 56.01% |
| Operating margin | (79.49%) | (203.27%) | (15.03%) |
| Net margin | (84.93%) | (210.75%) | (20.40%) |
| Free cash flow margin | (67.09%) | (166.48%) | (7.24%) |
| Return on equity | (133.44%) | (96.97%) | (15.32%) |
| Return on assets | (49.06%) | (64.40%) | (19.72%) |
| Return on invested capital | (218.09%) | (401.79%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack